@article{Guo2026, 
author = {Jinfeng Guo and Yunlei Chai and Kaiqi Gao and Yilin Sun and Yue Su and Ying Zhao and Yu Zhang and Yujun Jiang},
title = {Lacticaseibacillus paracasei JY062 postbiotic ameliorates DSS-induced colitis in mice through the miR-6974-5p/IL-17A/MAPK/AP-1 axis},
year = {2026},
journal = {Food Science and Human Wellness},
keywords = {Lacticaseibacillus paracasei, Postbiotic, miRNA, Ulcerative colitis, Inflammation},
url = {https://www.sciopen.com/article/10.26599/FSHW.2026.9251302},
doi = {10.26599/FSHW.2026.9251302},
abstract = {MicroRNAs (miRNAs) are key regulators of gene expression that play crucial roles in ulcerative colitis (UC) by regulating intestinal barrier function and modulating inflammatory signaling pathways. Lacticaseibacillus paracasei JY062 postbiotic (Pa JY062) has been shown to exert protective effects against colitis via regulating intestinal barrier function and mitigating inflammation; however, its underlying mechanisms involving the miRNA-mRNA axis remain unexplored. In this study, an integrated transcriptomic approach was employed to analyze the differential expression profiles of miRNAs and mRNAs in dextran sulfate sodium (DSS)-induced colitis mice treated with a high dose of Pa JY062. Initially, significantly differentially expressed miRNAs (DEM) were screened, followed by prediction of immune-related target genes for these miRNAs. Concurrently, significantly expressed gene mRNAs (DEG) were filtered from the transcriptomic data. Ultimately, based on the negative regulatory relationships between miRNAs and mRNAs, key regulatory pairs were identified: miR-6974-5p/IL-17A, miR-7094-1-5p/IL-17A, and miR-7013-3p/CCL19. In vitro validation using RAW264.7 cells demonstrated that miR-6974-5p attenuates inflammatory responses by directly targeting IL-17A, whereas neither miR-7094-1-5p nor miR-7013-3p significantly affected IL-17A or CCL19 expression under the same conditions. Additionally, dual-luciferase reporter assays confirmed that miR-6974-5p directly bound to the 3’ untranslated region of IL-17A, thereby suppressing its expression. Furthermore, in vivo overexpression of miR-6974-5p via adeno-associated virus (AAV)-mediated delivery significantly alleviated colitis symptoms and pathological damage in mice, accompanied by marked inhibition of the protein expression of IL-17A, MAPK key indicators (p38, p-p38, JNK, p-JNK), and AP-1. Combined treatment with Pa JY062 and miR-6974-5p overexpression achieved the most pronounced protective effects, further supporting that Pa JY062 acts through upregulating this miRNA. Collectively, these results demonstrate that Pa JY062 ameliorates DSS-induced colitis by upregulating miR-6974-5p, which directly targets IL-17A and suppresses the downstream MAPK/AP-1 signaling pathway, revealing a novel miRNA-dependent mechanism that provides a scientific basis for developing functional foods and miRNA-targeted therapies for UC.}
}